Apogee Therapeutics, Inc. (APGE)
NASDAQ:APGE
US Market
Holding APGE?
Track your performance easily

Apogee Therapeutics, Inc. (APGE) Financial Statements

106 Followers

Apogee Therapeutics, Inc. Financial Overview

Apogee Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.275; its P/E ratio is -26.86; Apogee Therapeutics, Inc. is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.78. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -44.12M$ -38.18M$ -20.84M--
EBITDA$ -44.09M$ -38.15M$ -20.84M--
Net Income Common Stockholders$ -33.82M$ -32.09M$ -20.84M$ -18.89M$ -12.53M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 676.23M$ 816.20M$ 422.85M$ 125.07M$ 141.33M
Total Assets$ 800.66M$ 823.66M$ 426.42M$ 130.67M$ 142.02M
Total Debt$ 4.08M$ 1.77M$ 0.00$ 0.00$ 0.00
Net Debt$ -672.14M$ -814.42M$ -422.85M$ -125.07M$ -141.33M
Total Liabilities$ 27.02M$ 22.18M$ 17.18M$ 17.61M$ 11.19M
Stockholders Equity$ 773.64M$ 801.48M$ 409.24M$ 113.05M$ 130.82M
Cash Flow-
Free Cash Flow$ -29.35M$ -31.95M-$ -14.57M$ -10.56M
Operating Cash Flow$ -29.30M$ -31.60M$ -19.88M$ -14.57M$ -10.56M
Investing Cash Flow$ -148.71M$ -51.74M$ -234.22M--
Financing Cash Flow$ -150.00K$ 450.52M$ 317.30M$ -1.69M-
Currency in USD

Apogee Therapeutics, Inc. Earnings and Revenue History

Apogee Therapeutics, Inc. Debt to Assets

Apogee Therapeutics, Inc. Cash Flow

Apogee Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis